Document is current

Any future updates will be listed below

Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer

Crossref DOI link: https://doi.org/10.1007/s12282-014-0543-1

Published Online: 2014-06-06

Published Print: 2014-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark